oAd/APP in combination with DC elicited strong and synergistic antitumor effects via either local or systemic administration, elucidating that oAd/APP can act as a potent adjuvant for optimizing DC vaccination and induction of potent tumor-specific adaptive immunity. The gene discussed is APP; the disease is neoplasm.